News | October 29, 2026

Boditech Med Partners With Biosys For Local Manufacturing In Brazil To Expand In South America

  • Local manufacturing expected to enhance price competitiveness and supply responsiveness
  • Boditech Med to provide key equipment and technology, while Biosys manages local investment and factory operations
  • Partnership aims to strengthen competitiveness in Brazil and explore growth opportunities across South America

Boditech Med Inc., a global provider of point-of-care diagnostic solutions, announced a strategic partnership with Biosys, a Brazilian in vitro diagnostics (IVD) company, for local manufacturing and supply. The collaboration aims to strengthen price competitiveness, improve supply responsiveness, and expand market share in Brazil. Building on this local manufacturing foundation, Boditech Med also plans to strengthen its presence across the broader South American market.

Biosys is an established IVD company operating in Brazil and has maintained an ongoing business relationship with Boditech Med. Through this agreement, the two companies will expand their existing distribution-focused partnership into local manufacturing, establishing a production and supply framework that leverages their respective expertise.

Under the agreement, Biosys will be responsible for investing in local manufacturing facilities and managing factory operations, while Boditech Med will provide essential production equipment and technology, along with key raw materials and semi-finished products. Boditech Med will also oversee production processes and quality standards to ensure the reliability of locally manufactured products. This collaborative framework will combine Biosys' local manufacturing and distribution capabilities with Boditech Med's diagnostic technologies.

Local manufacturing is expected to help reduce logistics and inventory costs while shortening product supply lead times. By establishing a more responsive supply system tailored to local demand, the partnership is also expected to enhance competitiveness in both the private healthcare market and public healthcare tenders. The companies plan to begin with cartridge assembly and packaging, gradually expanding production capacity and the scope of local manufacturing.

Building on its established business presence in Brazil, Boditech Med aims to renew its growth momentum through local manufacturing. As market conditions have evolved following the surge in demand for COVID-19 diagnostics, the company intends to strengthen price competitiveness and supply responsiveness through this partnership, with the goal of increasing its market share. Boditech Med also plans to explore further business expansion opportunities across South America, using Brazil as a strategic base.

Eui-Yul Choi, CEO of Boditech Med, stated, "Brazil is a key market for our expansion across South America. We expect that establishing a local manufacturing base will play an important role in strengthening our price competitiveness and supply responsiveness, supporting further market growth."

He added, "Through our partnership with Biosys, we aim to respond more flexibly to local market needs. By combining Boditech Med's diagnostic technologies with our partner's local business capabilities, we will continue to pursue growth opportunities in Brazil and across the broader South American market."

Source: Boditech Med Inc.